The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Silent cerebral infarcts occur despite regular blood transfusion therapy after first strokes in children with sickle cell disease
Open accessAbstract
Children with sickle cell disease (SCD) and strokes receive blood transfusion therapy for secondary stroke prevention; despite this, approximately 20% experience second overt strokes. Given this rate of second overt strokes and the clinical significance of silent cerebral infarcts, we tested the hypothesis that silent cerebral infarcts occur among children with SCD being transfused for secondary stroke prevention. A prospective cohort enrolled children with SCD and overt strokes at 7 academic centers. Magnetic resonance imaging and magnetic resonance angiography of the brain were scheduled approximately every 1 to 2 years; studies were reviewed by a panel of neuroradiologists. Eligibility criteria included regularly scheduled blood transfusion therapy. Forty children were included; mean pretransfusion hemoglobin S concentration was 29%. Progressive cerebral infarcts occurred in 45% (18 of 40 children) while receiving chronic blood transfusion therapy; 7 had second overt strokes and 11 had new silent cerebral infarcts. Worsening cerebral vasculopathy was associated with new cerebral infarction (overt or silent; relative risk = 12.7; 95% confidence interval, 2.65-60.5, P = .001). Children with SCD and overt strokes receiving regular blood transfusion therapy experience silent cerebral infarcts at a higher rate than previously recognized. Additional therapies are needed for secondary stroke prevention in children with SCD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Moyamoya Disease and Moyamoya Syndrome
Scott, R. M., & Smith, E. R. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0804622 · Cited by 1,768
Cerebrovascular accidents in sickle cell disease: rates and risk factors.
(1998) · PubMed · doi:10.1182/blood.v91.1.288 · Cited by 1,694
The natural history of stroke in sickle cell disease
Powars, D., Wilson, B., Imbus, C., Pegelow, C., & Allen, J. (1978) · The American Journal of Medicine · doi:10.1016/0002-9343(78)90772-6 · Cited by 594
Armstrong, F. D., Rj, T., Wang, W., Zimmerman, R. A., Pegelow, C. H., Miller, S., Moser, F. G., Bello, J. A., Hurtig, A., & Vass, K. (1996) · PubMed · Cited by 361
Pegelow, C. H. (2002) · Blood · doi:10.1182/blood.v99.8.3014 · Cited by 352
Cognitive Functioning and Brain Magnetic Resonance Imaging in Children With Sickle Cell Disease
Armstrong, F. D., Thompson, R. J., Wang, W., Zimmerman, R., Pegelow, C. H., Miller, S., Moser, F., Bello, J., Hurtig, A., & Kerstin Vass for the Neuropsychology Committee of the Cooperative Study of Sickle Cell Disease (1996) · Pediatrics · doi:10.1542/peds.97.6.864 · Cited by 334
Russell, M., Goldberg, H., Hodson, A., Kim, H., Halus, J., Reivich, M., & Schwartz, E. (1984) · Blood · doi:10.1182/blood.v63.1.162.162 · Cited by 324
Miller, S. T., Macklin, E. A., Pegelow, C. H., Kinney, T. R., Sleeper, L. A., Bello, J. A., DeWitt, L. D., Gallagher, D. M., Guarini, L., Moser, F. G., et al. (2001) · The Journal of Pediatrics · doi:10.1067/mpd.2001.117580 · Cited by 287
Self-citationPoor school and cognitive functioning with silent cerebral infarcts and sickle cell disease
Schatz, J., Brown, R. T., Pascual, J. M., Hsu, L., & DeBaun, M. R. (2001) · Neurology · doi:10.1212/wnl.56.8.1109 · Cited by 279
Self-citationDobson, S. R., Holden, K. R., Nietert, P. J., Cure, J. K., Laver, J. H., Disco, D., & Abboud, M. R. (2002) · Blood · doi:10.1182/blood.v99.9.3144 · Cited by 277
Cited by
Ware, R. E., Davis, B. R., Schultz, W. H., Brown, R. C., Aygun, B., Sarnaik, S., Odame, I., Fuh, B., George, A., Owen, W., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(15)01041-7 · Cited by 515
Self-citationBolaños-Meade, J., Fuchs, E. J., Luznik, L., Lanzkron, S. M., Gamper, C. J., Jones, R. J., & Brodsky, R. A. (2012) · Blood · doi:10.1182/blood-2012-07-438408 · Cited by 444
DeBaun, M. R., Jordan, L. C., King, A. A., Schatz, J., Vichinsky, E., Fox, C. K., McKinstry, R. C., Telfer, P., Kraut, M. A., Daraz, L., et al. (2020) · Blood Advances · doi:10.1182/bloodadvances.2019001142 · Cited by 434
Self-citationCentral nervous system complications and management in sickle cell disease
DeBaun, M. R., & Kirkham, F. J. (2016) · Blood · doi:10.1182/blood-2015-09-618579 · Cited by 263
Self-citationManagement of sickle cell disease from childhood through adulthood
Kanter, J., & Kruse-Jarres, R. (2013) · Blood Reviews · doi:10.1016/j.blre.2013.09.001 · Cited by 182
Metadata
- Authors
- Hulbert, M. L., McKinstry, R. C., Lacey, J. L., Moran, C. J., Panepinto, J. A., Thompson, A. A., Sarnaik, S. A., Woods, G. M., Casella, J. F., Inusa, B., Howard, J., Kirkham, F. J., Anie, K. A., Mullin, J. E., Ichord, R., Noetzel, M., Yan, Y., Rodeghier, M., & DeBaun, M. R.
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2011-01-20
- Volume
- 117
- Issue
- 3
- Pages
- 772-779
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W2127432854
- Cited by
- 262
- References
- 21
- FWCI
- 7.13
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Silent cerebral infarcts occur despite regular blood transfusion therapy after first strokes in children with sickle cell disease. https://app.cochat.ai/papers/10.1182/blood-2010-01-261123
- The paper
- Hulbert, M. L., McKinstry, R. C., Lacey, J. L., Moran, C. J., Panepinto, J. A., Thompson, A. A., Sarnaik, S. A., Woods, G. M., Casella, J. F., Inusa, B., Howard, J., Kirkham, F. J., Anie, K. A., Mullin, J. E., Ichord, R., Noetzel, M., Yan, Y., Rodeghier, M., & DeBaun, M. R. (2011). Silent cerebral infarcts occur despite regular blood transfusion therapy after first strokes in children with sickle cell disease. Blood. https://doi.org/10.1182/blood-2010-01-261123
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.